Specifically, POSTN was found to promote the expression of smooth muscle α-actin 2 (ACAT2) and COL1A1 by activating FAK/STAT3 signaling in HCC TME (Xiao et al., 2021). Here, STAT3 is linked to hepatocellular carcinoma.